PODOSAL OINTMENT

Indications

• Condylomata acuminata (genital warts)
• Bowenoid papulosis
• Certain types of skin cancers
• Actinic keratosis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on specific conditions and formulations.

Adults: Refer to the BNF for appropriate dosing information based on specific conditions and formulations.

Mechanism of action

Podophyllum exerts its therapeutic effects by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division. This inhibition leads to the disruption of the mitotic process in rapidly dividing cells, ultimately resulting in cell death. The compound's action is particularly effective against neoplastic cells and viral-infected cells, contributing to its use in oncology and dermatology.

Pharmacodynamics

The pharmacodynamics of podophyllum are characterized by its antimitotic and cytotoxic effects. By interfering with the normal cell cycle, particularly during the S and G2 phases, podophyllum induces apoptosis in affected cells. The extent of its effect is dose-dependent, with higher concentrations leading to increased cell death. Additionally, podophyllum has shown activity against certain viruses, including human papillomavirus (HPV), which is responsible for genital warts and other lesions.

Pharmacokinetics

Podophyllum is usually administered topically, which limits systemic absorption. When applied to the skin, the bioavailability is low, and systemic effects are minimal. However, when ingested or improperly used, it can lead to significant toxicity. The compound is metabolized in the liver, and its metabolites are excreted primarily via the kidneys. The half-life of podophyllum can vary based on the route of administration and the individual's metabolic rate.

Contra-indications

• Pregnancy
• Lactation
• Severe liver dysfunction
• Hypersensitivity to podophyllum or any of its components

Adverse effects

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Headache
• Dizziness
• Skin irritation
• Local necrosis at the application site

Interactions

• May interact with other cytotoxic agents
• Caution advised when used with anticoagulants due to potential for increased bleeding

Precautions

• Use with caution in patients with liver impairment
• Monitor for signs of toxicity, especially in patients receiving other medications that affect liver function
• Not to be used in large areas of skin or on open wounds

Pregnancy

Podophyllum is contraindicated during pregnancy due to its potential teratogenic effects.

Breast-feeding

The use of podophyllum during breastfeeding is not recommended due to the risk of serious adverse effects in the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical solution
• Gel
• Ointment

Indications

• Inflammatory conditions
• Pain management
• Topical antiseptic
• Excipient in pharmaceutical formulations

Dosage

Children: Refer to specific formulation and clinical guidelines for dosage.

Adults: Refer to specific formulation and clinical guidelines for dosage.

Mechanism of action

Resins exert their action through several mechanisms depending on the specific type. Many resins contain compounds that modulate inflammatory pathways, inhibit microbial growth, and exhibit antioxidant properties. For example, terpenoids in resin may interact with cellular receptors and enzymes that are involved in the inflammatory response, leading to reduced inflammation and pain.

Pharmacodynamics

Pharmacodynamics of resin varies based on its composition. Generally, the active components in resin can influence various biological pathways, including modulation of neurotransmitter release, alteration of cytokine production, and interference with cell signaling pathways associated with inflammation and infection. The effects can be dose-dependent and influenced by the route of administration.

Pharmacokinetics

The pharmacokinetics of resin is not well characterized due to its complex composition and variability among different types of resin. However, in general, the absorption of resin components can occur through oral, topical, or inhalation routes. Metabolism may occur in the liver, where certain terpenoids are converted into more water-soluble metabolites. Elimination typically occurs through urine and feces, although specific half-lives can vary widely.

Indications

• Acne vulgaris
• Psoriasis
• Warts
• Seborrheic dermatitis
• Dandruff
• Hyperkeratosis

Dosage

Adults: For topical application, salicylic acid is typically applied once or twice daily, depending on the formulation and condition being treated. Specific dosing guidelines should be followed as per the BNF.

Mechanism of action

Salicylic acid exerts its effects by penetrating the skin and exfoliating the stratum corneum through keratolytic action, which helps in the dissolution of keratin and the removal of dead skin cells. This action facilitates the clearance of pores and can reduce acne lesions. Additionally, salicylic acid has anti-inflammatory properties that can help to decrease swelling and redness associated with various skin conditions. The compound is also known to inhibit the activity of enzymes involved in the synthesis of prostaglandins, which are mediators of inflammation.

Pharmacodynamics

The pharmacodynamics of salicylic acid involve its ability to enhance the turnover of skin cells and reduce the cohesiveness of keratinocytes in the stratum corneum. This leads to increased desquamation and a reduction in the formation of microcomedones in acne. Its anti-inflammatory effects are mediated through the inhibition of cyclooxygenase enzymes, leading to decreased production of pro-inflammatory mediators. This contributes to the reduction of inflammation and pain in affected areas.

Pharmacokinetics

Salicylic acid is absorbed percutaneously when applied topically, with systemic absorption increasing with higher concentrations and prolonged application. Once absorbed, it is metabolized predominantly in the liver to various conjugates, which are then excreted by the kidneys. The elimination half-life can vary based on the formulation and concentration used. For topical applications, significant first-pass metabolism may occur, limiting systemic exposure and reducing potential systemic side effects.

Pregnancy

Salicylic acid is classified as pregnancy category C. Its use should be avoided during pregnancy unless the potential benefits outweigh the risks.

Breast-feeding

Salicylic acid is excreted in breast milk, and caution is advised when using it during breastfeeding.

Storage

Store in a cool, dry place away from direct light.